Top

CardioVascular and Interventional Radiology

Published in:

01-07-2007 | Review

The Current Role of Venous Sampling in the Localization of Endocrine Disease

Authors: Jeshen H. G. Lau, William Drake, Matthew Matson

Published in: CardioVascular and Interventional Radiology | Issue 4/2007

Abstract

Endocrine venous sampling plays a specific role in the diagnosis of endocrine disorders. In this article, we cover inferior petrosal sinus sampling, selective parathyroid venous sampling, hepatic venous sampling with arterial stimulation, adrenal venous sampling, and ovarian venous sampling. We review their indications and the scientific evidence justifying these indications in the diagnosis and management of Cushing’s syndrome, hyperparathyroidism, pancreatic endocrine tumors, Conn’s syndrome, primary hyperaldosteronism, pheochromocytomas, and androgen-secreting ovarian tumors. For each sampling technique, we compare its diagnostic accuracy with that of other imaging techniques and, where possible, look at how it impacts patient management. Finally, we incorporate venous sampling into diagnostic algorithms used at our institution.

Newell-Price J, Trainer P, Besser M, et al. (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 19(5):647–672PubMedCrossRef

Kaye TB, Crapo L (1990) The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 112:434PubMed

Hall WA, Luciano MG, Doppman JL, et al. (1994) Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120:817–820PubMed

Findling JW, Doppman JL (1994) Biochemical and radiological diagnosis of Cushing’s syndrome. Endocrinol Metab Clin North Am 23:511–537PubMed

Dwyer AJ, Frank JA, Doppman JL, et al. (1987) Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA enhanced MR imaging. Radiology 163:421–426PubMed

Doppman JL, Frank JA, Dwyer AJ, et al. (1988) Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. J Comput Assist Tomogr 12:728–735PubMedCrossRef

Liu C, Lo JC, Dowd CF, et al. (2004) Cavernous and inferior petrosal sinus sampling in the evaluation of ACTH-dependent Cushing’s syndrome. Clin Endocrinol 61:478–486CrossRef

Corrigan DF, Schaaf M, Whaley RA, et al. (1977) Selective venous sampling to differentiate ectopic ACTH secretion from pituitary Cushing’s syndrome. N Engl J Med 296:861–862PubMedCrossRef

Oldfield EH, Doppman JL, Nieman LK, et al. (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 325:897–905PubMedCrossRef

10.

Oldfield EH, Chrousos GP, Schulte HM, et al. (1985) Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 312:100–103PubMedCrossRef

11.

Teramoto A, Nemoto S, Takakura K, et al. (1993) Selective venous sampling directly from cavernous sinus in Cushing’s syndrome. J Clin Endocrinol Metab 76:637–641PubMedCrossRef

12.

Graham KE, Samuels MH, Nesbit GM, et al. (1999) Cavernous sinus sampling is highly accurate in distinguishing Cushing’s disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location. J Clin Endocrinol Metab 84(5):1602–1610PubMedCrossRef

13.

Lienhardt A, Grossman AB, Dacie JE, et al. (2001) Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 86(12):5711–5714PubMedCrossRef

14.

Storr HL, Afshar F, Matson M, et al. (2005) Factors influencing cure by transsphenoidal selective adenectomy in paediatric Cushing’s disease. Eur J Endocrinol 52(6):825–833CrossRef

15.

Sturrock ND, Jeffcoate WJ (1997) A neurological complication of inferior petrosal sinus sampling during investigation for Cushing’s disease: a case report. J Neurol Neurosurg Psychiatry 62:527–528PubMed

16.

Miller DL, Doppman JL, Peterman SB, et al. (1992) Neurologic complications of petrosal sinus sampling. Radiology 185:143–147PubMed

17.

Bonelli FS, Huston J III, Carpenter PC, et al. (2000) Adrenocorticotropic hormone-dependent Cushing’s syndrome: sensitivity and specificity of inferior petrosal sinus sampling. Am J Neuroradiol 21:690–696PubMed

18.

Yanovski JA, Cutler GB Jr, Doppman JL, et al. (1993) The limited ability of inferior petrosal sinus sampling with corticotrophin-releasing hormone to distinguish Cushing’s disease from pseudo-Cushing states or normal physiology. J Clin Endocrinol Metab 77:503–509PubMedCrossRef

19.

Yoshihiro Y, Davies DH, Nippoldt TB, et al. (1995) False-positive inferior petrosal sinus sampling in the diagnosis of Cushing’s disease. J Neurosurg 83:1087–1091

20.

Doppman JL, Chang R, Oldfield EH, et al. (1999) The hypoplastic inferior petrosal sinus: a potential source of false-negative results in petrosal sampling for Cushing’s disease. J Clin Endocrinol Metab 84(2):533–540PubMedCrossRef

21.

Lefournier V, Martinie M, Vasdev A, et al. (2003) Accuracy of bilateral inferior petrosal or cavernous sinuses sampling in predicting the lateralization of Cushing’s disease pituitary microadenoma: influence of catheter position and anatomy of venous drainage. J Clin Endocrinol Metab 88(1):196–203PubMedCrossRef

22.

Mamelak AN, Dowd CF, Tyrrell JB, et al. (1996) Venous angiography is needed to interpret inferior petrosal sinus and cavernous sinus sampling data for lateralizing adrenocorticoptropin-secreting adenomas. J Clin Endocrinol Metab 81(2):475–481PubMedCrossRef

23.

Boonstra CE, Jackson CE (1971) Serum calcium survey for hyperparathyroidism: results in 50000 clinic patients. Am J Clin Pathol 55:523–526PubMed

24.

Wermers RA, Khosla S, Atkinson EJ, et al. (1997) The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992. Ann Intern Med 126:433–440PubMed

25.

Davies M, Fraser WD, Hosking DJ (2002) The management of primary hyperparathyroidism. Clin Endocrinol 57:145–155CrossRef

26.

Jaskowiak N, Norton JA, Alexander HR, et al. (1996) A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg 224(3):308–322PubMedCrossRef

27.

Grant CS, van Heerden JA, Charboneau JW, et al. (1986) Clinical management of persistent and/or recurrent primary hyperparathyroidism. World J Surg 10:555–565PubMedCrossRef

28.

Brennan MF, Marx SJ, Doppman JL, et al. (1981) Results of reoperation for persistent and recurrent hyperparathyroidism. Ann Surg 94(6):671–676CrossRef

29.

Saxe AW, Brennan MF (1981) Strategy and technique of reoperative parathyroid surgery. Surgery 89(4):417–423PubMed

30.

Sugg SL, Fraker DL, Alexander RH, et al. (1993) Prospective evaluation of selective venous sampling for parathyroid hormone concentration in patients undergoing reoperations for primary hyperparathyroidism. Surgery 114:1004–1010PubMed

31.

Jones JJ, Brunaud L, Dowd CF, et al. (2002) Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism. Surgery 132:944–951PubMedCrossRef

32.

Ogilvie CM, Brown PL, Matson M, et al. (2005) Selective parathyroid venous sampling in patients with complicated hyperparathyroidism. 87th Annual Meeting of the Endocrine Society, San Diego, OR 30–2

33.

Mariani G, Gulec SA, Rubello D, et al. (2003) Preoperative localisation and radioguided parathyroid surgery. J Nucl Med 44:1443–1458PubMed

34.

Udelsman R (2000) Is unilateral neck exploration for parathyroid adenoma appropriate? Adv Surg 34:319–329PubMed

35.

Billotey C, Sarfati E, Aurango A, et al. (1996) Advantages of SPECT in technetium-99m-Sestamibi parathyroid scintigraphy. J Nucl Med 37(11):1773–1778PubMed

36.

De Feo ML, Colagrande S, Biagini C, et al. (2000) Parathyroid glands: combination of ^99mTc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 214:393–402PubMed

37.

Seehofer D, Steinmuller T, Rayes N, et al. (2004) Parathyroid hormone venous sampling before reoperative surgery in renal hyperparathyroidism: comparison with non-invasive localisation procedures and review of the literature. Arch Surg 139:1331–1338PubMedCrossRef

38.

King CM, Reznek RH, Dacie JE, et al. (1994) Imaging islet cell tumours. Clin Radiol 49:295–303PubMedCrossRef

39.

King AD, Ko GT, Yeung VT, et al. (1998) Dual phase spiral CT in the detection of small insulinomas of the pancreas. Br J Radiol 71:20–23PubMed

40.

Van Hoe L, Gryspeerdt S, Marchal G, et al. (1995) Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. AJR 165:1437–1439PubMed

41.

Kelekis NL, Semelka RC (1997) MRI of pancreatic tumours. Eur J Radiol 7:875– 886CrossRef

42.

Owen N, Sohaib SA, Peppercorn PD, et al. (2001) MRI of neuroendocrine tumours of the pancreas. Br J Radiol 74:968–973PubMed

43.

Semelka RC, Cumming MJ, Shoenut JP, et al. (1993) Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology 196:799–802

44.

Moore NR, Rogers CE, Britton BJ (1995) Magnetic resonance imaging of endocrine tumours of the pancreas. Br J Radiol 68:341–347PubMed

45.

Anderson MA, Carpenter C, Thompson NW, et al. (2000) Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95:2271–2277PubMedCrossRef

46.

Virgolini I, Traub-Weidinger T, Decristoforo C (2005) Nuclear medicine in the detection and management of pancreatic islet-cell tumours. Best Pract Res Clin Endocrinol Metab 19(2) 213–227PubMedCrossRef

47.

Jackson JE (2005) Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 19(2):229–239PubMedCrossRef

48.

Imamura M, Takahashi K, Adachi H, et al. (1987) Usefulness of selective arterial injection test for localisation of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 205:230–239PubMedCrossRef

49.

Doppman JL, Miller DL, Chang R, et al. (1991) Insulinomas: localization with selective intraarterial injection of calcium. Radiology 178:237–241PubMed

50.

Doppman JL, Miller DL, Chang R, et al. (1993) Intraarterial calcium stimulation test for detection of insulinomas. World J Surg 17:439–443PubMedCrossRef

51.

Doppman JL, Chang R, Fraker DL, et al. (1995) Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med 123:269–273PubMed

52.

O’Shea D, Rohrer-Theus AW, Lynn JA, et al. (1996) Localisation of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab 81(4):1623–1627PubMedCrossRef

53.

Tsagarakis S, Kaskarelis J, Malagari C, et al. (1997) Regionalization of occult pancreatic insulinomas with the arterial stimulation venous sampling (ASVS) technique. Clin Endocrinol (Oxf) 47:753–757CrossRef

54.

Kuzin NM, Egorov AV, Kondrashin SA, et al. (1998) Preoperative and intraoperative topographic diagnosis of insulinomas. World J Surg 22:593–598PubMedCrossRef

55.

Pereira PL, Roche AJ, Maier GW, et al. (1998) Insulinoma and islet cell hyperplasia: Value of the calcium intraarterial stimulation test when findings of other preoperative studies are negative. Radiology 206:703–709PubMed

56.

Brandle M, Pfammatter T, Spinas GA, et al. (2001) Assessment of selective arterial calcium stimulation and hepatic venous sampling to localise insulin-secreting tumours. Clin Endocrinol 55:357–362CrossRef

57.

Wiesli P, Brandle M, Schmid C, et al. (2004) Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinaemic hypoglycaemia: potential and Limitations. J Vasc Interv Radiol 15:1251–1256PubMed

58.

Doppman Jl, Miller DL, Chang R, et al. (1990) Gastrinomas: localisation by means of selective intraarterial injection of secretin. Radiology 174(1):25–29PubMed

59.

Thom Ak, Norton JA, Doppman JL, et al. (1992) Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas. Surgery 112:1002–1009PubMed

60.

Rosata FE, Bonn J, Shapiro M, et al. (1990) Selective arterial stimulation of secretin in localization of gastrinomas. Surg Gynecol Obstet 171:196–200

61.

Cohen MS, Picus D, Lairmore TC, et al. (1997) Prospective study of provocative angiograms to localize functional islet cell tumours of the pancreas. Surgery 122:1091–1100PubMedCrossRef

62.

Turner JJ, Wren AM, Jackson JE, et al. (2002) Localisation of gastrinomas by selective intra-arterial calcium injection. Clin Endocrinol (Oxf) 57:821–825CrossRef

63.

Young WF (2003) Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 144(6):2208–2213PubMedCrossRef

64.

Biglieri EG, Irony I, Kater CE, et al. (1989) Identification and implication of new types of mineralocorticoid hypertension. J Steroid Biochem 32:199–204PubMedCrossRef

65.

Irony I, Kater CE, Biglieri EG, et al. (1989) Correctable subsets of primary aldosteronism: primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertension 3:576–582

66.

Young WF, Stanson AW, Grant CS, et al. (1996) Primary aldosteronism: adrenal venous sampling. Surgery 120:913–920PubMedCrossRef

67.

Sawka AM, Young WF, Thompson GB, et al. (2001) Primary aldosteronism: factors associated with normalisation of blood pressure after surgery. Ann Intern Med 135:258–261PubMed

68.

Celen O, O’Brien MJ, Melby JC, et al. (1996) Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 131:646–650PubMed

69.

Fontes RG, Kater CE, Biglieri EG, et al. (1991) Reassessment of predictive value of the postural stimulation test in primary aldosteronism. Am J Hypertens 4:786–791PubMed

70.

Ganguly A, Dowdy AJ, Luetscher JA, et al. (1973) Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 36:401–404PubMedCrossRef

71.

Feltynowski T, Ignatowska-Switalska H, Wocial B, et al. (1994) Postural stimulation test in patients with aldosterone-producing adenomas. Clin Endocrinol 41:309–414

72.

Espiner EA, Ross DG, Yandle TG, et al. (2003) Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab 88:3637–3644PubMedCrossRef

73.

Harper R, Ferrett CG, McKnight JA, et al. (1999) Accuracy of CT scanning and adrenal vein sampling in the pre-operative localisation of aldosterone-secreting adrenal adenomas. Q J Med 92:643–650

74.

Phillips JL, Walther MM, Pezzullo JC, et al. (2000) Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 85:4526–4533PubMedCrossRef

75.

Doppman JL, Gill JR (1996) Hyperaldosteronism: sampling the adrenal veins. Radiology 198:309–312PubMed

76.

Doppman JL, Gill JR, Miller DL, et al. (1992) Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology 184:677–682PubMed

77.

Magill SB, Raff H, Shaker JL, et al. (2001) Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 86:1066–1071PubMedCrossRef

78.

Young WF, Stanson AW, Thompson GB, et al. (2004) Role for adrenal venous sampling in primary aldosteronism. Surgery 136:1227–1235PubMedCrossRef

79.

Sheaves R, Golding J, Reznek RH, et al. (1996) Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism. Eur J Endocrinol 134:308–313PubMedCrossRef

80.

Kloos RT, Gross MD, Francis IR, et al. (1995) Incidentally discovered adrenal masses. Endocr Rev 16:460–484PubMedCrossRef

81.

Young WF, Klee GG (1998) Primary aldosteronism: diagnostic evaluation. Endocrinol Metab Clin North Am 17:367–395

82.

Ilias I, Pacak K (2004) Clinical problem solving: current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 89(2):479–491PubMedCrossRef

83.

Newbould EC, Ross GA, Dacie JE, et al. (1991) The use of venous catheterization in the diagnosis and localization of bilateral phaeochromocytomas. Clin Endocrinol (Oxf) 35(1):55–59

84.

Pacak K, Goldstein DS, Doppman JL, et al. (2001) A “pheo” lurks: novel approaches for locating occult pheochromocytoma. J Clin Endocrinol Metab 86(8):3641–3646PubMedCrossRef

85.

Chew SL, Dacie JE, Reznek RH, et al. (1994) Bilateral phaeochromocytomas in von Hippel-Lindau disease: diagnosis by adrenal vein sampling and catecholamine assay. Q J Med 87(1):49–54PubMed

86.

DiSaia PJ, Creasman WT. (1997) Germ cell, stromal and other ovarian tumors. In: Clinical gynecologic oncology. Mosby-Yearbook, New York, p 351

87.

Kaltsas GA, Isidori AM, Kola BP, et al. (2003) The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J Clin Endocrinol Metab 88(6):2634–2643PubMedCrossRef

88.

Reznek RH, Armstrong P (1994) The adrenal gland. Clin Endocrinol 40:561–576

89.

Moltz L, Pickartz H, Sorensen R, et al. (1984) Ovarian and adrenal vein steroids in seven patients with androgen-secreting ovarian neoplasms: selective catheterization findings. Fertil Steril 42(4):585–593PubMed

90.

Surrey ES, De Zielger D, Cambone JC, et al. (1988) Preoperative localization of androgen-secreting tumours: clinical, endocrinologic and radiologic evaluation of ten patients. Am J Gynecol 158:1313–1322

91.

Bricaire C, Raynaud A, Benotmane A, et al. (1991) Selective venous catheterization in the evaluation of hyperandrogenism. J Endocrinol Invest 14(11):949–956PubMed

92.

Kaltsas GA, Mukherjee JJ, Kola BP, et al. (2003) Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women? Clin Endocrinol 59:34–43CrossRef

93.

Sorensen R, Moltz L, Schwartz U (1986) Technical difficulties of selective venous blood sampling in the differential diagnosis of female hyperandrogenism. Cardiovasc Interv Radiol 9:75–82CrossRef

94.

Moltz L, Schwartz U, Sorensen R, et al. (1984) Ovarian and adrenal vein steroids in patients with nonneoplastic hyperandrogenism: selective catheterization findings. Fertil Steril 42:69–75PubMed

Title: The Current Role of Venous Sampling in the Localization of Endocrine Disease
Authors: Jeshen H. G. Lau
William Drake
Matthew Matson
Publication date: 01-07-2007
Publisher: Springer-Verlag
Published in: CardioVascular and Interventional Radiology / Issue 4/2007
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-007-9028-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Current Role of Venous Sampling in the Localization of Endocrine Disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2007

Contrast-Enhanced Abdominal Angiographic CT for Intra-abdominal Tumor Embolization: A New Tool for Vessel and Soft Tissue Visualization

Angioplasty for Non-arteriosclerotic Renal Artery Stenosis: The Efficacy of Cutting Balloon Angioplasty Versus Conventional Angioplasty

Visceral and Renal Artery Complications of Suprarenal Fixation during Endovascular Aneurysm Repair

Thrombin Injection for Acute Hemorrhage Following Angiography

Cerebral Venous Congestion as Indication for Thrombolytic Treatment

Percutaneous Vein Occlusion with Small Intestinal Submucosa: An Experimental Pilot Study in Swine and Sheep